Provivi® today announced successful pheromone biosynthesis scale up at the EW Biotech Scale-Up plant in Leuna, Germany.
Horizon Technology Finance Corporation, a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, announced today it has provided a $20 million venture loan facility to Provivi, Inc., of which $10 million has been initially funded.
Provivi® is pleased to announce an agreement with Syngenta Crop Protection AG for the development of a new, natural and sustainable pheromone-based product concept for the effective management of major rice pests in Indonesia.
Provivi® today announced it has completed an $85 million Series C financing.
Provivi™ today announced the hiring of Dr. Timothy (Tim) Taylor, Vice President of Formulation and Tariq Salim, Vice President of Supply Chain.
Provivi™ today announced the successful production of the fall armyworm (Spodoptera frugiperda) pheromone at ton scale.
Provivi™ today announced successful pheromone production scale up at the Bio Base Europe Pilot Plant (BBEPP) in Belgium.
Provivi™ today announced that it has added three senior leaders to its team: William Evanko, Vice President of Engineering; Dr. Thomas Clark, Vice President of Field Development; and Dr. Richard Pederson, Vice President of Chemistry.
Provivi™ today announced a $5 million expansion to a $31.5 million Series B, bringing the round total to $36.5 million.
Provivi™ today announced a multi-year supply agreement with a leading agricultural company. The contract marks Provivi’s largest commercial agreement to date.